Replies to post #8310 on BioCurex, Inc.(fka BOCX)

[tommyb]

Sorry to hear that ... it must have been a very difficult time for both of you.

I am only questioning the value of RECAF as an early detection tool as a way to make people aware of other issues that could impact the acceptance of RECAF by the medical community. It's not as cut and dried as one might intitially think. Many "better" products have fallen by the wayside over the years for reasons un-related to the technology itself. IMO, anyone who believes RECAF as a general screening tool is reason enough to invest in Biocurex, might want to give it some more thought.

I'm open to other comments!